| Typicality: | 0.462 |
| Saliency: | 0.308 |
| in patients | 5 | other |
| directly | 4 | manner |
| most significantly | 2 | manner |
| expression → be correlated with → tumor progression | 5 |
| expression → be associated with → tumor progression | 4 |
| expression → contribute to → tumor progression | 4 |
| expression → be associated with → cancer progression | 4 |
| negative | neutral | positive |
| 0.465 | 0.478 | 0.057 |
| Raw frequency | 17 |
| Normalized frequency | 0.308 |
| Modifier score | 0.750 |
| Perplexity | 209.785 |